Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD

Molecular Therapy(2023)10.1016/j.ymthe.2023.09.004Source: DataRank Database

Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD is a research paper published in Molecular Therapy (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.13)OA: greenTopics (27)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Toshinao Kawai ORCID,Kazuhiko Nakabayashi ORCID,Yumiko Nakazawa,Fumihiro Goto,K. Okamura ORCID

Live enrichment

PubMed:37705244 PMC:PMC10727956 OpenAlex:https://openalex.org/W4386629622

Japan Agency for Medical Research and Development

Grant: 17ek0109167h0002

National Center for Child Health and Development

Grant: 2020B-2

National Center for Child Health and Development

Grant: 2023B-17

National Center for Child Health and Development

Grant: 28-1

FWCI

2.13

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10727956/pdf/main.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525001623004914?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001623004914?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10727956

Fields of Study

Virus-based gene therapy researchCAR-T cell therapy researchRNA Interference and Gene Delivery

MeSH Terms

NADPH Oxidase 2Clonal HematopoiesisAdultGranulomatous Disease, ChronicHumansMyelodysplastic SyndromesRetroviridaeGenetic TherapyNADPH Oxidases

Keywords

BiologyCancer researchGenetic enhancementTransactivationMyeloidGeneticsGeneGene expressionRetroviral vectorWT1insertional mutagenesisHypermutationCgdApobec3Mecom

Sustainable Development Goals

SDG 0: Good health and well-being